About Us   Technology   Media   Applications   Clinical Trials   Publications   News & Events   Investors  

Smoking Cessation in Chronic Obstructive Pulmonary Disease - Double-Blind Placebo Control Safety and Feasibility Study

Be'er Ya'akov Mental Health Center, Israel

1 July, 2009

A clinical trial in Chronic Obstructive Pulmonary Disease Patients with an Addiction to Smoking, has begun at the Mental Health Center in Be'er Ya'akov, Israel.

The study aim is to assess the efficacy of the Company's Deep TMS device in inducing smoking cessation in chronic obstructive pulmonary disease patients. Between 90 and 120 patients are expected to participate in the trial. The trial will be a blinded placebo-controlled study.

Related Links
Contact
Copyright 2009 @ Brainsway. Address: 19 Hartum st. Bynet Building, 3rd floor, Har Hotzvim, Jerusalem, ISRAEL, zip code: 91451 Tel: 972-2-5813140, Fax: 972-2-5812517, Email: info@brainsway.com

Created by Catom.